Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,209.00    19.00 (0.87%)
Bid:
2,212.00
Ask:
2,214.00
Spread: 2.00 (0.09%)
Market Cap: £22.41b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Update on Action valuation

30 Jun 2016 07:00

RNS Number : 7191C
3i Group PLC
30 June 2016
 

30 June 2016

 

 

3i Group plc

Update on Action valuation

Since the publication of 3i Group plc's ("3i" or "the Group") financial results for the year to 31 March 2016, 3i has received a number of approaches in respect of Action, the Group's largest portfolio investment.

 

Action continues to grow strongly and, based on trading to mid-June, is performing on a trajectory similar to its 2015 performance with a similar level of like-for-like sales growth. Action is currently also on track to open materially more new stores this year than it did last year.

 

In light of the third-party interest in Action and its continuing growth and financial trajectory, the Board of 3i has decided to increase the book value of its investment in Action to £1,464 million1 after liquidity discount as at 30 June 2016 (31 March 2016: £902 million). This implies a post discount run-rate EBITDA multiple of 18.2x applied to the run-rate earnings as at 31 March 20162. The book valuation of £1,464 million amounts to a less than 15x projected run-rate EBITDA as at 31 December 20162 on the assumption that Action continues to grow on its current trajectory for the remainder of this calendar year.

 

3i is actively engaged in the further development of Action and is not intending to sell its investment or organise a flotation of Action in the near future.

 

We will publish our Q1 performance update on 27 July 2016, which will include this adjustment and the results of our quarterly portfolio valuation.

 

Notes

1. Action's valuation currency is euros. The GBP equivalents at 30 June 2016 in this update have been calculated at a currency exchange rate of €1.2168:£1.

 

2. Action is valued using a multiple of its run-rate earnings for the 12 months to the quarter end preceding the reporting period. The valuation uplift to £1,464 million at 30 June 2016 is calculated using run-rate earnings to 31 March 2016. The valuation as at 31 March 2017 will be calculated using run-rate earnings to 31 December 2016.

 

- Ends -

 

For further information, please contact:

 

Silvia SantoroInvestor Relations DirectorTel: 020 7975 3258

 

Toby Bates

Interim Communications DirectorTel: 020 7975 3032

 

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity, Infrastructure and Debt Management. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

The financial information in this update is unaudited and is presented on 3i's non-GAAP Investment basis in order to provide users with the most appropriate description of the drivers of 3i's performance. Although this update has been prepared based on reasonable assumptions, any statements about the future outlook of 3i or its investments may be influenced by factors that could cause actual outcomes and results to be materially different.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUGPQUPQGRB
Date   Source Headline
6th Jun 20164:46 pmRNSDirector/PDMR Shareholding
1st Jun 201610:39 amRNSDTR 6.3.5
1st Jun 201610:36 amRNSDoc re. 2016 Annual Report and Accounts
31st May 20163:12 pmRNSTotal Voting Rights
31st May 20163:11 pmRNSDirector/PDMR Shareholding
19th May 20164:45 pmRNSDirector/PDMR Shareholding
19th May 20162:15 pmRNSDirector/PDMR Shareholding
19th May 20167:01 amRNSAnnouncement of interest in bond buy-backs
19th May 20167:00 amRNSFull year results to 31 March 2016
29th Apr 20162:54 pmRNSTotal Voting Rights
29th Apr 20162:52 pmRNSDirector/PDMR Shareholding
1st Apr 20163:11 pmRNSPortfolio Update
31st Mar 20164:16 pmRNSTotal Voting Rights
31st Mar 20164:06 pmRNSDirector/PDMR Shareholding
29th Feb 20162:58 pmRNSTotal Voting Rights
29th Feb 20162:55 pmRNSDirector/PDMR Shareholding
8th Feb 20163:05 pmRNSDirector/PDMR Shareholding
29th Jan 20163:11 pmRNSTotal Voting Rights
29th Jan 20163:07 pmRNSDirector/PDMR Shareholding
28th Jan 20167:00 amRNSQ3 Performance update
12th Jan 20161:56 pmRNSDirector/PDMR Shareholding
8th Jan 20169:48 amRNSPortfolio Update
31st Dec 201511:32 amRNSTotal Voting Rights
31st Dec 201511:27 amRNSDirector/PDMR Shareholding
9th Dec 201511:10 amRNSBlocklisting Interim Review
30th Nov 20153:33 pmRNSTotal Voting Rights
30th Nov 20153:31 pmRNSDirector/PDMR Shareholding
12th Nov 20159:50 amRNSDoc re. half yearly report 2015
12th Nov 20157:00 amRNSHalf Yearly Report
30th Oct 201511:50 amRNSTotal Voting Rights
30th Oct 201511:49 amRNSDirector/PDMR Shareholding
19th Oct 20159:42 amRNSDirectorate Change
6th Oct 201510:47 amRNSPortfolio Update
30th Sep 20152:55 pmRNSTotal Voting Rights
30th Sep 20152:52 pmRNSDirector/PDMR Shareholding
4th Sep 20153:49 pmRNSDirector/PDMR Shareholding
28th Aug 20153:38 pmRNSTotal Voting Rights
28th Aug 20153:36 pmRNSDirector/PDMR Shareholding
11th Aug 201511:47 amRNSDirector/PDMR Shareholding
7th Aug 20153:19 pmRNSDirector/PDMR Shareholding
31st Jul 20154:05 pmRNSTotal Voting Rights
31st Jul 20154:02 pmRNSDirector/PDMR Shareholding
30th Jul 20159:45 amRNSDirector/PDMR Shareholding
30th Jul 20159:42 amRNSDirector/PDMR Shareholding
29th Jul 20151:36 pmRNSDirector/PDMR Shareholding
29th Jul 20157:00 amRNSFY2016 Q1 performance update
7th Jul 201510:20 amRNSPortfolio Update
30th Jun 20152:53 pmRNSTotal Voting Rights
30th Jun 20152:51 pmRNSDirector/PDMR Shareholding
26th Jun 20159:57 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.